Deep Responders Represent a Group with Excellent Survival in Patients with Metastatic Colorectal Cancer (MCRC) Treated with Triplet Chemotherapy Regimens (TCR)

Annals of Oncology ◽

10.1093/annonc/mdu165.238 ◽

2014 ◽

Vol 25 ◽

pp. ii90 ◽

Author(s):

Bazarbashi Shouki ◽

Al Jubran Ali ◽

Al Zahrani Ahmad ◽

Soudy Hussein ◽

Shoukri Mohammed

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Triplet Chemotherapy

Download Full-text

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

Targeted Oncology ◽

10.1007/s11523-015-0400-y ◽

2015 ◽

Vol 11 (3) ◽

pp. 293-308 ◽

Author(s):

Fotios Loupakis ◽

Alexander Stein ◽

Marc Ychou ◽

Frank Hermann ◽

Antonieta Salud ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Clinical Studies ◽

Practical Guide ◽

Triplet Chemotherapy

Download Full-text

KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy

10.18632/oncotarget.25180 ◽

2018 ◽

Vol 9 (41) ◽

pp. 26279-26290 ◽

Author(s):

Gemma Bruera ◽

Francesco Pepe ◽

Umberto Malapelle ◽

Pasquale Pisapia ◽

Antonella Dal Mas ◽

...

Keyword(s):

Colorectal Cancer ◽

Next Generation Sequencing ◽

Clinical Outcome ◽

Metastatic Colorectal Cancer ◽

Next Generation ◽

Braf Mutations ◽

Triplet Chemotherapy ◽

Generation Sequencing

Download Full-text

Abstract C35: Different prognostic relevance ofKRASgenotype in metastatic colorectal cancer (MCRC) patients fitting for triplet chemotherapy plus VEGF-inhibitor, unfit for intensive medical treatment and post-progression.

10.1158/1535-7163.targ-13-c35 ◽

2013 ◽

Author(s):

Gemma Bruera ◽

Katia Cannita ◽

Edoardo Alesse ◽

Corrado Ficorella ◽

Enrico Ricevuto

Keyword(s):

Colorectal Cancer ◽

Medical Treatment ◽

Metastatic Colorectal Cancer ◽

Triplet Chemotherapy ◽

Prognostic Relevance ◽

Download Full-text

Prospective Observational Study for Dpyd and Ugt1A1 Deficiency-Associated Toxicity in Patients with Metastatic Colorectal Cancer (Mcrc) Receiving Triplet Chemotherapy with Capecitabine, Irinotecan and Oxaliplatin (Coi)

Annals of Oncology ◽

10.1093/annonc/mdu333.35 ◽

2014 ◽

Vol 25 ◽

pp. iv181

Author(s):

F.S. Falvella ◽

S. Cheli ◽

C. Maggi ◽

R. Iacovelli ◽

M. Pierotti ◽

...

Keyword(s):

Colorectal Cancer ◽

Observational Study ◽

Metastatic Colorectal Cancer ◽

Prospective Observational Study ◽

Triplet Chemotherapy

Download Full-text

Effectiveness of triplet chemotherapy plus bevacizumab intensive regimen (FIr-B/FOx) and secondary liver surgery according to KRAS genotype in metastatic colorectal cancer (MCRC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e14028 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e14028-e14028

Author(s):

G. Bruera ◽

K. Cannita ◽

D. Di Giacomo ◽

G. Troncone ◽

A. Marchetti ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Liver Surgery ◽

Triplet Chemotherapy ◽

Triplet Chemotherapy Plus Bevacizumab ◽

Intensive Regimen

Download Full-text

Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e14575 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e14575-e14575

Author(s):

Gemma Bruera ◽

Katia Cannita ◽

Alessandra Tessitore ◽

Alessio Cortellini ◽

Jean Christophe Sabourin ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Triplet Chemotherapy ◽

Prognostic Relevance ◽

Triplet Chemotherapy Plus Bevacizumab

Download Full-text

Intensive first line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: Preliminary phase II data and individual limiting toxicity syndromes prediction by pharmacogenomic biomarkers

Annals of Oncology ◽

10.1093/annonc/mdy151.205 ◽

2018 ◽

Vol 29 ◽

pp. v57 ◽

Author(s):

G. Bruera ◽

S. Massacese ◽

F. Pepe ◽

U. Malapelle ◽

A. Dal Mas ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Wild Type ◽

Triplet Chemotherapy ◽

Colorectal Cancer Patients ◽

Preliminary Phase

Download Full-text

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype

International Journal of Oncology ◽

10.3892/ijo.2013.2179 ◽

2013 ◽

Vol 44 (1) ◽

pp. 17-26 ◽

Author(s):

GEMMA BRUERA ◽

KATIA CANNITA ◽

ALDO VICTOR GIORDANO ◽

ROBERTO VICENTINI ◽

CORRADO FICORELLA ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Line Treatment ◽

Second Line ◽

Triplet Chemotherapy ◽

Colorectal Cancer Patients ◽

Triplet Chemotherapy Plus Bevacizumab

Download Full-text

423P From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.08.944 ◽

2021 ◽

Vol 32 ◽

pp. S546

Author(s):

G.M. Bol ◽

S.C.M.W. van Nassau ◽

M. Bond ◽

I. Scheerman ◽

J.V. Breeschoten ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Metastatic Colorectal Cancer ◽

Triplet Chemotherapy

Download Full-text

Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdx261.271 ◽

2017 ◽

Vol 28 ◽

pp. iii95-iii96

Author(s):

Gemma Bruera ◽

Francesco Pepe ◽

Umberto Malapelle ◽

Pasquale Pisapia ◽

Antonella Dal Mas ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Outcome ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Massive Parallel Sequencing ◽

Parallel Sequencing ◽

Triplet Chemotherapy ◽

Colorectal Cancer Patients

Download Full-text